Matthew Brent Laurens MD
HIV/AIDS Pediatrics, Pediatric Travel and Tropical Medicine, Pediatric Vaccinology and Vaccine Preventable Diseases
Professor of Pediatrics, Tenured, University of Maryland School of Medicine
Join to View Full Profile
22 S Greene StBaltimore, MD 21201
Phone+1 410-706-5328
Fax+1 410-706-1204
Dr. Laurens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matthew Laurens is a pediatric infectious disease specialist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center and University of Maryland Upper Chesapeake Medical Center. He received his medical degree from Mercer University School of Medicine and has been in practice 16 years. He specializes in pediatrics, pediatric travel and tropical medicine, and pediatric vaccinology and vaccine preventable diseases and is experienced in pediatric infectious disease.
Education & Training
University of MarylandFellowship, Pediatric Infectious Diseases, 2005 - 2008
Tulane UniversityResidency, Pediatrics, 2001 - 2005
Mercer University School of MedicineClass of 2001
Certifications & Licensure
MD State Medical License 2005 - 2026
LA State Medical License 2002 - 2006
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine Start of enrollment: 2019 Jul 08
Publications & Presentations
PubMed
- 1 citationsSafety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection.Andrea A Berry, Thomas L Richie, L W Preston Church, Matthew B Laurens, Colleen Boyce
Malaria Journal. 2025-03-17 - Protective targets of PfSPZ vaccines identified from whole-genome sieve analysis of isolates from malaria vaccine efficacy trials in West Africa.Ankit Dwivedi, Ryan J Scalsky, David G Harris, Thomas C Stabler, Biraj Shrestha
Medrxiv. 2025-03-06 - Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children.Nginache Nampota-Nkomba, Osward M Nyirenda, Shrimati Datta, Victoria Mapemba, Priyanka D Patel
Eclinicalmedicine. 2025-03-01
Press Mentions
- Extra Spring COVID Boosters Cleared for Some Americans | HealthApril 21st, 2023
- Extra COVID-19 Booster Now Open to Some High-Risk AmericansApril 20th, 2023
- FDA Clears Extra COVID Booster for Some High-Risk AmericansApril 19th, 2023
- Join now to see all
Grant Support
- Safety, immunogencity, and efficacy of PfSPZ LARC2 malaria vaccine in malaria-exposed adults and childrenUNIVERSITY OF MARYLAND BALTIMORE2024–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
